Andere talen AlzeCure Pharma AB

Aandelen

ALZCUR

SE0010133785

Beurs gesloten - Nasdaq Stockholm Andere beurzen 12:49:50 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,89 ^SEK	-1,56%		-8,70%	-39,23%

25/04	AlzeCure Pharma AB (publ) rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
10/04	Jan Lundberg heeft een onbekend minderheidsbelang in AlzeCure Pharma AB (publ) (OM : ALZCUR) verworven.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

AlzeCure Pharma publishes prospectus	29/04
AlzeCure publishes its interim report for January – March 2024	25/04
AlzeCure Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg invests in AlzeCure and is proposed for election to its board	10/04
Jan Lundberg acquired an unknown minority stake in AlzeCure Pharma AB (OM : ALZCUR).	10/04
AlzeCure Pharma publishes its Annual Report for 2023	04/04
AlzeCure presents new data regarding the TrkA-NAM pain project at IASP 2024	03/04
AlzeCure Pharma AB Presents New Data Regarding the TrkA-NAM Pain Project at IASP 2024	03/04
AlzeCure to partake in Redeye Theme, Alzheimer on March 21	15/03
AlzeCure to partake in Redeye Theme: Alzheimer on March 21	14/03
AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at Leading Alzheimer's Conference	07/03
AlzeCure presents new preclinical data with NeuroRestore ACD856 at leading Alzheimer's conference	07/03
AlzeCure Pharma AB Publishes Clinical Results Supporting Continued Development of NeuroRestore ACD856 Against Alzheimer's	05/03
AlzeCure publishes clinical results supporting continued development of NeuroRestore ACD856 against Alzheimer's	05/03
AlzeCure's Alzheimer's project NeuroRestore ACD856 is granted an additional patent	29/02
AlzeCure publishes its Year-end report for January – December 2023	27/02
AlzeCure Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	27/02
AlzeCure Pharma broadcasts live expert event on Alzheimer's around highly current gamma-secretase modulators	12/02
AlzeCure Pharma AB Announces Live Expert Event on Alzheimer's Around Highly Current Gamma-Secretase Modulators	12/02
AlzeCure gets Late Breaking abstract of new preclinical data with ACD856 accepted at AD/PD 2024 conference	06/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen AlzeCure Pharma AB

Aandelen

ALZCUR

SE0010133785

Andere talen

Filters